Free Trial

Moleculin Biotech (MBRX) SEC Filings & 10K Form

Moleculin Biotech logo
$0.87 -0.04 (-4.80%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.88 +0.00 (+0.01%)
As of 04/17/2025 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Moleculin Biotech SEC Filings

DateFilerForm TypeView
04/09/2025
3:31 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
04/01/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:04 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/24/2025
6:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:30 PM
Moleculin Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
4:15 PM
Moleculin Biotech (Filer)
Form DEF 14A
03/13/2025
4:15 PM
Moleculin Biotech (Filer)
Form DEF 14A
03/06/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
9:09 AM
Moleculin Biotech (Filer)
Form 424B5
02/24/2025
4:16 PM
Moleculin Biotech (Filer)
Form RW
02/14/2025
4:51 PM
ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
Form SCHEDULE 13G/A
02/13/2025
3:17 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:25 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:25 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
7:31 AM
Moleculin Biotech (Filer)
Form S-1/A
02/10/2025
7:32 AM
Moleculin Biotech (Filer)
Form S-1/A
02/10/2025
7:33 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
8:18 AM
Moleculin Biotech (Filer)
Form S-1/A
01/27/2025
11:08 AM
Moleculin Biotech (Filer)
Form 8-K/A
01/27/2025
8:16 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:02 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
12/03/2024
4:20 PM
Moleculin Biotech (Filer)
Form POS AM
11/18/2024
7:20 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:20 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:35 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
4:09 PM
Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:00 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM
CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM
George Robert E. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
11/06/2024
7:04 PM
Climaco John M (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:05 PM
Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:06 PM
Moleculin Biotech (Issuer)
Yan Joy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:27 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:43 PM
Moleculin Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/25/2024
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:40 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
4:15 PM
Moleculin Biotech (Filer)
Form PRE 14A
08/19/2024
3:10 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
9:06 AM
Moleculin Biotech (Filer)
Form 424B3
08/16/2024
3:54 PM
Moleculin Biotech (Filer)
Form 424B4
08/15/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
08/15/2024
10:21 AM
Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
8:57 PM
Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
7:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
8:05 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
7:35 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:00 AM
Moleculin Biotech (Filer)
Form S-1/A
07/22/2024
4:31 PM
Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/10/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
4:01 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
06/25/2024
5:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:01 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:02 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:00 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:01 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
7:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:05 PM
Moleculin Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/16/2024
7:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:38 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:55 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
8:00 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Moleculin Biotech (Filer)
Form 10-K/A
04/25/2024
7:23 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MBRX) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners